NEUROSENSE THERAPEUTICS LTD
NRSN·M74240108·US·Common Stock·Healthcare - Biotechnology
NRSN (NEUROSENSE THERAPEUTICS LTD) is held by 9 institutional investors as of Q2 2026. Largest holders: UBS Group AG ($78,218), COMMONWEALTH EQUITY SERVICES, LLC ($16,400), PNC FINANCIAL SERVICES GROUP, INC. ($15,228). Net institutional sentiment: Mixed.
9
Holders
(3 Elite)
$157,405
Total Value
50% (6)
Consensus
3 buying - 3 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 9, 2026 · Insiders Apr 1, 2026 · Activists none · Congress none
InsiderBHBinder HagitVest 200K shMar 26, 2026
InsiderEOEisenberg OrVest 200K shMar 26, 2026
InsiderRNRussek-Blum NivaVest 200K shMar 26, 2026
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
415 holders · $877.5B
415 holders · $299.1B
400 holders · $151.4B
397 holders · $414.1B
394 holders · $97.5B
393 holders · $111.5B
390 holders · $230.1B
385 holders · $302.9B
385 holders · $51.8B
382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer